TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    caution
    Investing

    3 Red Flags That Signal it’s Time to Sell: Learning From the Past

    The lessons investors can learn from Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), Sierra Wireless, Inc. (TSX:SW)(NASDAQ:SWIR), and Ballard Power Systems Inc.…

    Read more »

    The Motley Fool
    Investing

    Why Shares of Valeant Pharmaceuticals Intl Inc. Plunged Yet Again

    Debt refinancing reminds investors of continuing trouble at Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Is the Reward Worth the Risk?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has a plan to get out of debt, but it's going to take pristine execution.

    Read more »

    The Motley Fool
    Investing

    Another Cut for Valeant Pharmaceuticals Intl Inc.

    With another disappointing earnings release, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may be yet another case of death by a thousand…

    Read more »

    The Motley Fool
    Investing

    Stay Away From Valeant Pharmaceuticals Intl Inc.

    Investors: stop dreaming of a comeback. Just stay away from Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Investing

    Are We Witnessing the Resurgence of Valeant Pharmaceuticals Intl Inc.?

    As Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) prepares to release a new drug to the market, the company still has a…

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. “Investable?”

    Debt and scandal aside, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) might very well be a very good contrarian investment thanks to…

    Read more »

    The Motley Fool
    Investing

    What Could Go Right for Valeant Pharmaceutical Intl Inc.?

    What if Joseph Papa can turn Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) around?

    Read more »

    Investing

    Valeant Pharmaceuticals Intl Inc. Crushed by Citron Research: Find Out Who’s Next

    Andrew Left of Citron Research has another top pick for short-sellers looking for another opportunity to capitalize on accounting manipulations…

    Read more »

    The Motley Fool
    Investing

    Will These Companies Be Back in Vogue in 2017?

    Will shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), BlackBerry Ltd. (TSX:BB)(NASDAQ:BBRY), or Bombardier, Inc. (TSX:BBD.B) be back in vogue in…

    Read more »

    Investing

    Checklist: How to Find a Great Stock

    Free cash flow, low debt levels, and strong shareholder returns are paramount to the success of an investment. CCL Industries…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Should You Take a Contrarian Shot?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is hitting new multi-year lows. Is the bottom in sight?

    Read more »